« Back
Home /
Sovleplenib

Sovleplenib

Item no.	DCC-DC48364-250mg
Manufacturer	DCChemicals
CASRN	1415792-84-5
Amount	250 mg
Quantity options	100 mg 1 g 250 mg
Category	Reagents & Chemicals Building Blocks & Intermediates general
Type	Chemicals
Specific against	other
Smiles	S(C)(N1CCC(C2C=CC(C3C=C4C(=C(N=3)NC[C@@H]3CNCCO3)N=CC=N4)=CC=2)CC1)(=O)=O
ECLASS 10.1	32160000
ECLASS 11.0	32160000
UNSPSC	12000000
Available
Manufacturer - Applications	Sovleplenib is a highly potent inhibitor of spleen tyrosine kinase (Syk), derived from the innovative research disclosed in patent WO2012167733 A1. This compound demonstrates significant potential in modulating Syk-mediated signaling pathways, offering a promising therapeutic approach for conditions where Syk activity plays a critical role. Its development underscores the ongoing advancements in targeted kinase inhibition, providing a valuable tool for both research and potential clinical applications in immune-related and inflammatory diseases.
Molecular Weight	482, 598403453827

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 250 mg

available

Delivery expected until 10/23/2025

Express Delivery: Save 1 days

Compare

Add to wishlist

Get an offer